{
    "code": "10000874",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000874",
    "time": "2016-01-08 03:16:45",
    "許可證字號": "衛署菌疫輸字第000874號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/01\/19",
    "發證日期": "98\/01\/19",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000087408",
    "中文品名": "癌思停 注射劑 (瑞士廠)",
    "英文品名": "Avastin Injection",
    "適應症": "1.轉移性大腸直腸癌(mCRC)：\r\n(1)Avastin(Bevacizumab)與含有irinotecan\/5-fluorouracil\/Leucovorin或 5-fluorouracil\/Leucovorin之化學療法合併使用，可作為轉移性大腸或直腸癌患者之第一線治療。\r\n(2)Avastin與含有5-fluorouracil\/Leucovorin\/Oxaliplatin之化學療法合併使用，可作為先前接受過以Fluoropyrimidine為基礎之化學療法無效且未曾接受過Avastin治療之轉移性大腸或直腸癌患者之治療。\r\n(3)Avastin與含有Fluoropyrimidine-oxaliplatin之化學療法合併使用，可作為第一線已接受過Avastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。\r\n\r\n2.轉移性乳癌(mBC)：\r\nAvastin與Paclitaxel合併使用，可作為HER2 (-)轉移性乳癌患者之第一線治療。\r\n\r\n3.惡性神經膠質瘤(WHO第4級) - 神經膠母細胞瘤：\r\nAvastin 單獨使用可用於治療曾接受標準放射線治療且含Temozolomide在內之化學藥物治療失敗之多型性神經膠母細胞瘤(Glioblastoma Multiforme)復發之成人患者。\r\n\r\n4.晚期、轉移性或復發性非鱗狀非小細胞肺癌(NSCLC)：\r\nAvastin與Carboplatin及Paclitaxel合併使用，可作為無法切除之晚期、轉移性或復發性非小細胞肺癌患者之第一線治療。\r\n\r\n5.復發性卵巢上皮細胞、輸卵管或原發性腹膜癌 (Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer)： -Avastin與Carboplatin及Gemcitabine合併使用，可以做為曾接受過第一線含鉑類藥物(Platinum-based)化學治療間隔至少6個月再復發(即，對含鉑藥物具感受性)，且未曾接受過Bevacizumab或其他血管內皮細胞生長因子(VEGF)抑制劑或血管內皮細胞生長因子接受器之標靶藥物(VEGF Receptor-targeted Agents)治療之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌患者之治療。 -Avastin併用paclitaxel、topotecan或pegylated liposomal doxorubicin，可以做為接受過含鉑類藥物 (Platinum-based) 化學治療後6個月內再復發 (即，對含鉑藥物具抗藥性)、之前接受不超過2種化療療程且未曾接受過bevacizumab或其他血管內皮細胞生長因子 (VEGF) 抑制劑或血管內皮細胞生長因子接受器之標靶藥物 (VEGF receptor-targeted agents)之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌患者的治療。",
    "劑型": "270注射劑",
    "包裝": "4毫升小瓶裝 16毫升小瓶裝 100小瓶以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "BEVACIZUMAB",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市松山區民生東路三段１３４號９樓",
    "主製造廠": {
        "製造廠名稱": "F430257000  F. HOFFMANN-LA ROCHE LTD.",
        "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
        "製造廠公司地址": "",
        "製造廠國別": "SWITZERLAND",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F390030000  Roche Singapore Technical Operations Pte.Ltd.",
            "製造廠廠址": "10 Tuas Bay Link, 637394 Singapore",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "F430258000  F. HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "GRENZACHERSTRASSE 124, CH-4070 BASEL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "bulk"
        },
        {
            "製造廠名稱": "F460768000  GENENTECH, INC.",
            "製造廠廠址": "1 ANTIBODY WAY, OCEANSIDE, CA 92056, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "bulk"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000800",
            "成分名稱": "BEVACIZUMAB",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "100008740001-2014-08-20.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=008&Type=9"
        },
        {
            "title": "100008740001-2014-02-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=007&Type=9"
        },
        {
            "title": "100008740001-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=006&Type=9"
        },
        {
            "title": "100008740002___20110711.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=005&Type=9"
        },
        {
            "title": "100008740002___20100923.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=004&Type=9"
        },
        {
            "title": "100008740002___20100609.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=003&Type=9"
        },
        {
            "title": "100008740001___20110711.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=002&Type=9"
        },
        {
            "title": "100008740001___20100923.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=001&Type=9"
        },
        {
            "title": "100008740007-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=006&Type=8"
        },
        {
            "title": "100008740006-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=005&Type=8"
        },
        {
            "title": "100008740005-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=004&Type=8"
        },
        {
            "title": "100008740004-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=003&Type=8"
        },
        {
            "title": "100008740003-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=002&Type=8"
        },
        {
            "title": "100008740002-102-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000874&Seq=001&Type=8"
        }
    ]
}